Vimarsana
Biggest News Aggregation in the World

Pictor Pictarray News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pictor Pictarray. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pictor Pictarray Today - Breaking & Trending Today

Pictor Receives CE Mark for its PictArray SARS-CoV-2 Antibody Test, Indicating Whether Patients Require COVID-19 Booster - Vimarsana News

Pictor Receives CE Mark for its PictArray SARS-CoV-2 Antibody Test, Indicating Whether Patients Require COVID-19 Booster

Following a recent funding round raising $6.1 million (NZD $8.8 million), biotech company Pictor today announced it has received confirmation of CE registration for its PictArray SARS-CoV-2 IgG enzyme-linked

Business.Scoop » Pictor Receives CE Mark For PictArray™ SARS-CoV-2 Antibody Test, Indicating Whether Patients Require COVID-19 Booster - Vimarsana News

Business.Scoop » Pictor Receives CE Mark For PictArray™ SARS-CoV-2 Antibody Test, Indicating Whether Patients Require COVID-19 Booster

Business Scoop provides news and views on Business and Markets from New Zealand

Bolstered By Investment, Pictor Partners with Mobility Health to Offer PictArray™ SARS-CoV-2 Antibod - Vimarsana News

Bolstered By Investment, Pictor Partners with Mobility Health to Offer PictArray™ SARS-CoV-2 Antibod

$6.1 Million investment for Pictor — led by Marko Bogoievski and K One W One Ltd. — to aid the market development of novel antibody testing and other in vitro diagnosticsLOS ANGELES--(BUSINESS WIRE)--Following a new investment of $6.1 million (NZD $8.8 million), biotech company Pictor today announced a partnership w...